Chen Pauline, Tran Kelvin, Korah Tessy
Psychiatry, University of Florida, Gainesville, USA.
Psychiatry, University of Florida, Gainsville, USA.
Cureus. 2021 Jan 9;13(1):e12594. doi: 10.7759/cureus.12594.
The psychiatric risks of epidural steroid injections for chronic pain in a geriatric patient with no prior psychiatric history are presented here. A 76-year old Caucasian female presented to the emergency department with her family for an inability to sleep, confusion, and behavioral outbursts. The mood instability and psychosis were reported as having started a week after her third epidural steroid injection for low-back pain associated with a prior fall. After 12 days of mixed treatment outcomes and increasing paranoia without any localized neurological findings, the patient was transferred to the geriatric psychiatry unit. Upon admission to the inpatient unit, she was loud, grandiose, verbally aggressive, unable to sleep, hyper-religious, paranoid, and identified her husband and daughter as demons. The patient was started on risperidone and valproic acid for the management of psychosis and manic symptoms. Hyper-religiosity and paranoia greatly improved within a week, though the patient remained very talkative and tangential, with a disorganized thought process. Valproic acid was titrated to 500 mg twice a day, yielding a level of 56.2 ug/ml, accompanied by improvement to mild talkativeness and circumstantiality. She was able to interact appropriately, with minimal lorazepam requirement, and discharged with a linear thought process and absence of psychosis. On outpatient follow up, there were minimal residual mania and no recurrence of psychosis, allowing her to be weaned off valproic acid and to discontinue risperidone. Two months later, symptoms resolved completely. The persistence of this patient's psychosis for nearly one month, and mania for about three months, underscores the importance of careful risk-benefit analysis before initiating epidural steroids. This is particularly important in elderly patients who may be more susceptible to psychiatric adverse effects that can outlast any analgesic benefits.
本文介绍了一名无精神病史的老年患者接受硬膜外类固醇注射治疗慢性疼痛的精神风险。一名76岁的白人女性因无法入睡、意识模糊和行为爆发,与家人一起前往急诊科就诊。据报告,在她因先前跌倒导致的腰痛接受第三次硬膜外类固醇注射一周后,出现了情绪不稳定和精神病症状。经过12天混合治疗效果不佳且偏执情绪加剧,但无任何局部神经学发现后,患者被转至老年精神病科。入院时,她大声喧哗、夸大、言语攻击性强、无法入睡、过度虔诚、偏执,还将丈夫和女儿认作恶魔。患者开始服用利培酮和丙戊酸来控制精神病和躁狂症状。一周内,过度虔诚和偏执症状有了很大改善,不过患者仍非常健谈且离题,思维过程紊乱。丙戊酸剂量滴定至每日两次,每次500毫克,血药浓度为56.2微克/毫升,同时健谈和离题症状改善至轻度。她能够进行适当互动,只需少量劳拉西泮,出院时思维过程连贯且无精神病症状。门诊随访时,残留躁狂症状轻微,精神病未复发,她得以停用丙戊酸并逐渐停服利培酮。两个月后,症状完全消失。该患者的精神病症状持续了近一个月,躁狂症状持续了约三个月,这凸显了在开始硬膜外类固醇注射前进行仔细的风险效益分析的重要性。这在老年患者中尤为重要,因为他们可能更容易受到精神方面的不良反应影响,且这些影响可能比对任何止痛效果的持续时间更长。